Drugs / INS19 CAR-T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06209671 | Jan 2024 → Jan 2025 | B-cell acute lymphoblastic leukemia | Beijing Immunochina Medical Science & Technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INS19 CAR-T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06209671 ↗ |